Acellular Pertussis
📧 Sign up to get email alerts when something new happens for Acellular Pertussis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines [Phase 3]
Phase 3 trial comparing three lots of GSK DTaP-IPV candidate vaccine to DTaP + IPV vaccines; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of a booster dose of Infanrix Hexa in healthy infants born to mothers vaccinated with Boo…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). [Phase 3]
Phase 3 immunogenicity and safety trial evaluating combined or separate vaccines against common childhood diseases in infants (2, 4, 6 month…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058 [Phase 4]
A Phase 4 clinical trial update evaluating immunogenicity and reactogenicity of Boostrix ten years after prior booster vaccination.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants [Phase 3]
Phase 3 clinical trial update on the immunogenicity, safety and reactogenicity of the combined DTPa-IPV vaccine in healthy infants; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults [Phase 3]
Phase 3 trial assessing immunogenicity and safety of coadministering GSK Tdap vaccine Boostrix with GSK influenza vaccine Fluarix in adults.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents [Phase 4]
A Phase 4 trial assessing immunogenicity and safety of Boostrix using a new syringe in adolescents aged 10 to 15 years; results completed an…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years [Phase 3]
Phase 3 trial assessing safety and immunogenicity of GSK Boostrix (Tdap) in adults 19–64; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children [Phase 3]
Phase 3 trial update evaluating the immunogenicity and safety of GSK Boostrix Polio vaccine in 3- and 4-year-old children.
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 immunogenicity and safety study of GSK's GSK2202083A vaccine in healthy infants aged 2, 3, and 4 months completed.
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease [Phase 4]
Phase 4 trial update on US-licensed combined tetanus, diphtheria, and meningococcal vaccines; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants [Phase 4]
Phase 4 trial updating safety and reactogenicity of DTPa-IPV/Hib vaccine administered at 3, 4, 5 and 18 months in healthy infants; completed…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children [Phase 3]
Phase 3 trial update assessing safety of a booster dose of Boostrix vaccine in healthy Vietnamese children; results posted in 2016. Conditio…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants [Phase 4]
Phase 4 trial update on immunogenicity and safety of Infanrix Hexa in infants, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants [Phase 2]
Phase 2 trial of GSK2202083A vaccine in healthy infants completed; multiple conditions tested including tetanus, hepatitis B, Hib, polio, ac…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial assessing safety and immunogenicity of booster doses for new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (GSK217744) in chi…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers [Phase 3]
Phase 3 safety trial of Infanrix-IPV+Hib vaccine in healthy Vietnamese toddlers completed with results posted
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Evaluation of Boostrix™10 Years After Previous Booster Vaccination [Phase 4]
Phase 4 trial update evaluating Boostrix 10 years after previous booster vaccination; completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine [Phase 3]
Phase 3 trial update on the immunogenicity and safety of Infanrix-IPV+Hib vaccine from GlaxoSmithKline, completed with posted results in 201…
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years [Phase 3]
Phase 3 trial updating immunogenicity and safety of Kinrix+ (MMR) with and without Varicella in healthy children 4-6 years; completed with r…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 [Phase 3]
Phase 3 trial update assessing persistence of Tdap vaccine (Boostrix) over 1, 3, 5, and 9 years after initial dose and immunogenicity/safety…
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. [Phase 3]
Phase 3 trial evaluating Boostrix vaccine versus Decavac for tetanus and acellular pertussis; completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children [Phase 4]
Phase 4 study of a new formulation of the DTPa-HBV-IPV/Hib vaccine as a booster in children aged 18-23 months; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines [Phase 3]
Phase 3 clinical trial update of a pneumococcal vaccine booster in healthy children 11-18 months previously primed with the same vaccines; s…